Controlled-Release Paxil Is Effective and Well Tolerated for Social Anxiety Disorder

MAY 01, 2004
Susan Farley

A multicenter, randomized, double-blind, flexible-dose study showed that 3 times as many patients with social anxiety disorder achieved remission while taking Paxil CR, compared with those taking placebo. The study, published in the Journal of Clinical Psychiatry, also showed that patients had a significantly reduced score on the Liebowitz Social Anxiety Scale, as well as on Fear or Anxiety and Avoidance subscales. Paxil CR is the first and only controlled-release selective serotonin reuptake inhibitor indicated for social anxiety disorder, the most common type of anxiety disorder. Paxil CR also is indicated for treating depression, panic disorder, and premenstrual dysphoric disorder.



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.